Minimal anhepatic technique for living donor liver transplantation using right liver graft
Seong Hoon Kim, Jun‐sik Yoo, Sung‐Sik Han, Sang Jae Park, Soon‐ae Lee, Woo Jin Lee, Joong‐Won Park, Chang‐Min Kim – 29 October 2007
Increasing calories, decreasing morbidity and mortality: Is improved nutrition the answer to better outcomes in patients with biliary atresia?
Christine Carter‐Kent, Kadakkal Radhakrishnan, Ariel E. Feldstein – 29 October 2007
Use of splenic artery embolization to relieve tense ascites following liver transplantation in a patient with paroxysmal nocturnal hemoglobinuria
Charissa Y. Chang, Ashwani K. Singal, Sri V. Ganeshan, Thomas D. Schiano, Robert Lookstein, Sukru Emre – 29 October 2007 – Recurrent venous thrombosis following liver transplantation for Budd‐Chiari syndrome is common, particularly in the setting of an underlying myeloproliferative disorder. We describe a patient who developed refractory ascites due to portal vein thrombosis following liver transplantation for Budd‐Chiari syndrome in the setting of paroxysmal nocturnal hemoglobinuria.
Reply: To MELD or not to MELD: Early assessment of prognosis in fulminant hepatic failure
Silvina Yantorno, Federico Villamil – 29 October 2007
Modified Charlson Comorbidity Index for predicting survival after liver transplantation
Michael L. Volk, Jose C. Hernandez, Anna S. Lok, Jorge A. Marrero – 29 October 2007 – The benefit of liver transplantation (LT) is determined not only by the severity of illness, but also by the likelihood of posttransplantation survival. Current models are unable to accurately predict which patients will have the best posttransplant survival. We hypothesized that the Charlson Comorbidity Index (CCI), which includes nine comorbidities, could be used to predict survival after LT. We performed a retrospective study of 624 patients undergoing LT, with a median follow‐up time of 4.3 yr.
Natural history of alcohol use disorders in liver transplant patients
Andrea DiMartini – 29 October 2007
What is addiction, what is alcoholism?
Thomas P. Beresford – 29 October 2007
Results of liver transplantation: With or without milan criteria?
Vincenzo Mazzaferro – 29 October 2007
The liver in celiac disease
Alberto Rubio‐Tapia, Joseph A. Murray – 29 October 2007 – Celiac disease is a common (1% prevalence) chronic immune‐mediated disorder of the small intestine induced by dietary wheat, barley, and rye. Several hepatic disorders have been described in association with celiac disease. Isolated hypertransaminasemia with nonspecific histologic changes in a liver biopsy is the commonest hepatic presentation of celiac disease. A gluten‐free diet normalizes liver enzymes and histologic changes in most patients.
Features and distribution of CD8 T cells with human leukocyte antigen class I–specific receptor expression in chronic hepatitis C
Paula Bonorino, Vincent Leroy, Tania Dufeu‐Duchesne, Stefania Tongiani‐Dashan, Nathalie Sturm, Martine Pernollet, Eric Vivier, Jean‐Pierre Zarski, Patrice N. Marche, Evelyne Jouvin‐Marche – 29 October 2007 – CD8+ T cells represent a sizable component of the liver inflammatory infiltrate in chronic hepatitis C and are thought to contribute to immune‐mediated tissue injury.